Ionis Pharmaceuticals Inc... (IONS)
NASDAQ: IONS
· Real-Time Price · USD
72.39
1.02 (1.43%)
At close: Oct 15, 2025, 3:59 PM
72.32
-0.10%
After-hours: Oct 15, 2025, 04:21 PM EDT
1.43% (1D)
| Bid | 71 |
| Market Cap | 11.54B |
| Revenue (ttm) | 944.24M |
| Net Income (ttm) | -268.22M |
| EPS (ttm) | -1.76 |
| PE Ratio (ttm) | -41.13 |
| Forward PE | -22.62 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 73.95 |
| Volume | 2,816,476 |
| Avg. Volume (20D) | 2,443,807 |
| Open | 71.42 |
| Previous Close | 71.37 |
| Day's Range | 71.24 - 73.92 |
| 52-Week Range | 23.95 - 73.92 |
| Beta | 0.33 |
| Ex-Dividend Date | n/a |
About IONS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IONS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IONS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsIonis Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+5.22%
Ionis Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+34.83%
Ionis Pharmaceuticals shares are trading higher after studies showed olezarsen reduced triglycerides and acute pancreatitis events with favorable safety and tolerability.
